Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Plasma renin measurement in the management of hypertension: the V and R hypothesis.

× No keyword cloud information.

13 in total

Review 1. Relevance of the plasma renin hormonal control system that regulates blood pressure and sodium balance for correctly treating hypertension and for evaluating ALLHAT.

Authors: John H Laragh; Jean E Sealey
Journal: Am J Hypertens Date: 2003-05 Impact factor: 2.689

2. Renin system analysis: a rational method for the diagnosis and treatment of the individual patient with hypertension.

Authors: J D Blumenfeld; J H Laragh
Journal: Am J Hypertens Date: 1998-07 Impact factor: 2.689

3. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Authors:
Journal: JAMA Date: 2002-12-18 Impact factor: 56.272

4. Age versus urinary sodium for judging renin, aldosterone, and catecholamine levels: studies in normal subjects and patients with essential hypertension.

Authors: P Weidmann; C Beretta-Piccoli; W H Ziegler; G Keusch; Z Glück; F C Reubi
Journal: Kidney Int Date: 1978-12 Impact factor: 10.612

Review 5. Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group.

Authors: G L Bakris; M Williams; L Dworkin; W J Elliott; M Epstein; R Toto; K Tuttle; J Douglas; W Hsueh; J Sowers
Journal: Am J Kidney Dis Date: 2000-09 Impact factor: 8.860

6. Possible role of renin in hypertension as suggested by renin-sodium profiling and inhibition of converting enzyme.

Authors: D B Case; J M Wallace; H J Keim; M A Weber; J E Sealey; J H Laragh
Journal: N Engl J Med Date: 1977-03-24 Impact factor: 91.245

7. Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension.

Authors: M H Alderman; S Madhavan; W L Ooi; H Cohen; J E Sealey; J H Laragh
Journal: N Engl J Med Date: 1991-04-18 Impact factor: 91.245

8. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Authors: Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal: JAMA Date: 2003-05-14 Impact factor: 56.272

Plasma renin measurement in the management of hypertension: the V and R hypothesis.

Review 1. Relevance of the plasma renin hormonal control system that regulates blood pressure and sodium balance for correctly treating hypertension and for evaluating ALLHAT.

2. Renin system analysis: a rational method for the diagnosis and treatment of the individual patient with hypertension.

3. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

4. Age versus urinary sodium for judging renin, aldosterone, and catecholamine levels: studies in normal subjects and patients with essential hypertension.

Review 5. Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group.

6. Possible role of renin in hypertension as suggested by renin-sodium profiling and inhibition of converting enzyme.

7. Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension.

8. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

9. Long-term efficacy of captopril in renovascular and essential hypertension.

10. Secondary hypertension. A streamlined approach to diagnosis.

1. Metabolomics, Lipid Pathways, and Blood Pressure Change.

2. Angiotensin-converting enzyme inhibitor use in the year 2005.

3. Your drug, my drug, or our drugs: how aggressive should we be with antihypertensive therapy?

4. Cardiovascular events in hypertension trials of Angiotensin-converting enzyme inhibitors.